Sohail Tavazoie

This inventor holds 28 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 11 EPO patents, primarily in Cancer Treatment. Top assignees: The Rockefeller University, Rgenix, Inc., Inspirna, Inc.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sohail Tavazoie. Retrieved from https://idiyas.com/inventor/sohail-tavazoie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 4)

EPO Patents = 11 (Patent Applications = 14)

Average Co-Inventor Count = 2.4

ph-index = 6

Forward Citations = 107(Granted Patents)

Company Filing History:

25 out of 751

The Rockefeller University

where one patent can have more than one assignee

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

Metastatic Cancer

Melanoma

Angiogenesis

MERTK Antibodies

Colon Cancer

Drug Resistance

Myeloid Suppressor Cells

LXR Agonists

Creatine Transport

Quantification

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12582667 - COMPOSITIONS AND METHODS TO TREAT METASTATIC GASTROINTESTINAL CANCER (2026-03-24),

2. 12502368 - TREATMENT AND DIAGNOSIS OF MELANOMA (2025-12-23),

3. 12162942 - Anti-MERTK agonistic antibodies and uses thereof (2024-12-10),

4. 12060619 - Treatment of angiogenesis disorders (2024-08-13),

5. 11865094 - Treatment and diagnosis of melanoma (2024-01-09),

6. 11648220 - Methods for the treatment of myeloid derived suppressor cells related disorders (2023-05-16),

7. 11613588 - Anti-mertk agonistic antibodies and uses thereof (2023-03-28),

8. 11225524 - Anti-MERTK agonistic antibodies and uses thereof (2022-01-18),

9. 10945978 - Treatment and diagnosis of melanoma (2021-03-16),

10. 10894989 - Treatment of angiogenesis disorders (2021-01-19),

11. 10717704 - Inhibitors of creatine transport and uses thereof (2020-07-21),

12. 10669296 - LXR agonists and uses thereof (2020-06-02),

13. 10543183 - Treatment and diagnosis of melanoma (2020-01-28),

14. 10406128 - Treatment and diagnosis of colon cancer (2019-09-10),

15. 10337065 - tRNA quantification (2019-07-02),

Title: The Innovative Journey of Inventor Sohail Tavazoie

Introduction: Sohail Tavazoie is a renowned inventor based in New York, NY, known for his groundbreaking contributions to the field of innovation and patents.

Latest Patents: Sohail Tavazoie holds several patents in the areas of biotechnology and medical research, with his latest patent focusing on a novel method for early cancer detection using genetic markers.

Career Highlights: With a background in molecular biology and genetics, Sohail Tavazoie has had a distinguished career working in top research institutions before venturing into entrepreneurship to bring his inventions to the market.

Collaborations: Throughout his career, Sohail Tavazoie has collaborated with leading scientists, medical professionals, and technology experts to further develop and refine his inventions, leading to impactful solutions in the healthcare industry.

Conclusion: Sohail Tavazoie's relentless pursuit of innovation and his commitment to improving lives through his inventions have solidified his reputation as a visionary inventor in the vibrant landscape of New York City.

Profile summary based on public USPTO records.